Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

pharma

Newtrend set to make IPO

BRIEF: Hengrui Pharma to raise up to $1.3 billion in Hong Kong IPO

Jiangsu Hengrui Pharmaceuticals Co. Ltd. (1276.HK; 600276.SH) launched its Hong Kong IPO on Thursday, aiming to sell 225 million shares at a price range of HK$41.45 to HK$44.05 per share,…
May 15, 2025
1276.HK 600276.SHG

CStone Finds Tonic in Steady Stream of Drug Approvals, Licensing Deals

Cancer drug specialist reported its first significant revenue in 2020, following a string of milestones capped by a $200 million investment from Pfizer Key takeaways: Strong upfront licensing fees helped…
April 30, 2021

Recent Articles

Newtrend set to make IPO
May 15, 2025

BRIEF: Hengrui Pharma to raise up to $1.3 billion in Hong Kong IPO

1276.HK 600276.SHG
April 30, 2021

CStone Finds Tonic in Steady Stream of Drug Approvals, Licensing Deals

RELATED ARTICLES

  1. Hengrui Pharma
    December 19, 2024
    Hengrui Pharma accelerates bid for global brand status
    600276.SHG
  2. March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  3. February 19, 2025
    BRIEF: Sany Heavy plans Hong Kong listing to raise up to $1.5 billion
    600031.SHG
  4. December 17, 2024
    BRIEF: Minieye IPO to raise up to $100 million in Hong Kong IPO
  5. December 12, 2024
    Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
  6. February 4, 2025
    BRIEF: Guming to raise $220 million in Hong Kong IPO
    1364.HK
  7. May 12, 2025
    BRIEF: CATL targets $4 billion in Hong Kong IPO, poised to become year’s top listing
    300750.SHE
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.